期刊文献+

Ⅱ型糖尿病患者听力损害的临床研究 被引量:5

Study on Correlation of Hearing Loss in type 2 diabetics mellitus
下载PDF
导出
摘要 目的观察Ⅱ型糖尿病对扩展高频测听及畸变产物耳声发射(distortion product otoacousticemission,DPOAE)的影响。方法选择自觉听力正常32例和异常的糖尿病患者28例及正常对照组30例进行扩展高频测听及DPOAE的检测,对其结果进行对照比较。结果同一年龄段糖尿病组扩展高频测听阈值较对照组升高,17~40岁患者12kHz及以上频率闽值增高有显著意义(P<0.05),41~55岁年龄组10~14kHz频率闽值增高有显著意义(P<0.05),糖尿病患者的DPOAE幅值在1000~8000Hz出现下降,其中在2000,4000,8000Hz均有统计学意义。结论 DPOAE和扩展高频测听可以在早期检测出糖尿病患者的听力损害,临床上可作为Ⅱ型糖尿病患者耳蜗功能早期变化的有效监测手段。 Objective To observe the efects of diabetes mellitus on amplitude of distortion product otoacoustic emissions(DPOAE). Methods forty diabetic patients with normal heating and forty with unnormal heating and forty healthy people as control were collected in this study.The ampiltude of extended high-frequency audiometry and DPOAE was measured and the data were calculated in the three groups. Restdts At each frequency tested, the DM subjects had higher hearing thresholds than the control subjects, however, only the differences between the two groups were significant above 12 kHz at age from 20 to 40 years old and above 10 kHz at age from 41 to 55 years old(P〈0.05) .The amplitude of DPOAE in diabetic patients decerased in 1000-8000 Hz and had statistical significant difference at 2000,4000and 8000Hz compared with the contorl group.Conclusion DPOAE and Extended high-frequency audiometry could be used as means of the early detection of heating loss in patients with diabetes mellitus, so they can be used as effectives index for detecting early changes of cochlear function in patients with type 2 diabetes.
出处 《中国中西医结合耳鼻咽喉科杂志》 2012年第6期404-407,共4页 Chinese Journal of Otorhinolaryngology in Integrative Medicine
基金 连云港市卫生局医学重点人才课题(编号ZC228)
关键词 Ⅱ型糖尿病 扩展高频测听 畸变产物耳声发射 听力损害 type 2 diabetes mellitus Extended high-frequency audiometry distortion porduct otoacoustic emissions hearing loss
  • 相关文献

参考文献10

  • 1Erdem T,Ozturan O,Miman MC. Exploration of the early auditory effect hyperlipoproteinemia and diabetes mellitus using otoacuoustic emission[J].European Archives of Oto-rhino-laryngology,2003,(02):62-66.
  • 2Gorga MP,Nelson K,Davis T. Distortion product otoacoustic emission test performance when both2f1-f2 and 2f2-f1 are used to predict auditory status[J].Journal of the Acoustical Society of America,2000,(04):2128-2135.
  • 3崔小康,任建民,许安廷,肖晓燕,樊云霞,孙磊.2型糖尿病患者听力损害的相关性分析[J].山东大学学报(医学版),2007,45(11):1144-1147. 被引量:11
  • 4黄选兆;汪吉宝.实用耳鼻咽喉学第2版[M]北京:人民卫生出版社,2011793-794.
  • 5Kazmierczak H,Doroszewska G. Metabolic disorders in vertigo linnitus,and hearing loss[J].Tinnitus,2001,(01):54-58.
  • 6Lasisi OA,Nwaorgu OG,Bella AF. Cochleovestibular complications of diabetes mellitus in Lbadan,Nigeria[J].Congress Series,2003,(10):1325-1328.
  • 7Sasson FC,Salvatore T,Tranchino G. Cochlear dysfunction in type 2 diabetes:a complication independent of neuropathy and acute hyperglycemia[J].Metabol Clin,1999,(11):1346-1350.
  • 8王士礼,陈学明,毕道周,叶燕芬,何士方.实验性糖尿病大鼠内耳毛细血管超微结构变化[J].听力学及言语疾病杂志,2006,14(4):278-279. 被引量:11
  • 9Tomisawa Hideo. Diabetic changes in sttia vascularis in humans:a study of PAS-Stained temporal bone sections[J].Journal of Otolaryngology of Japan,2000,(11):1227-1237.
  • 10张金平,梁象逢,刘伟.糖尿病患者的听力损害[J].国外医学(耳鼻咽喉科学分册),2005,29(6):376-378. 被引量:9

二级参考文献37

  • 1王士礼,陈学明,毕道周,叶燕芬,何士方,孙星梅.实验性链脲佐菌素糖尿病性聋动物模型制备的研究[J].听力学及言语疾病杂志,2004,12(6):404-406. 被引量:7
  • 2于德民,吴锐,尹潍,袁咏.实验性链脲佐菌素糖尿病动物模型的研究[J].中国糖尿病杂志,1995,3(2):105-109. 被引量:425
  • 3王士礼,陈学明,毕道周,叶燕芬,何士方.实验性糖尿病大鼠内耳毛细血管超微结构变化[J].听力学及言语疾病杂志,2006,14(4):278-279. 被引量:11
  • 4Lasisi OA, Nwaorgu OGB, Bella AF. Cochleovestibular complications of diabetes mellitus in Ibadan, Nigeria. Int Congress Series, 2003,1240: 1325-1328.
  • 5Kakarlapudi V, Sawyer R, Staecker H. The effect of diabetes on sensorineural hearing loss. Otol Neurotol, 2003, 24(3): 382-386.
  • 6Chung SS, Ho EC, Lam KS, et al. Contribution of polyol pathway to diabetes-induced oxidative stress. J Am Soc Nephrol, 2003, 14( 8 Suppl 3): S233-236.
  • 7Cosentino F, Eto M, De Paolis P, et al. High glucose causes up regulation of cyclooxygenase-2 and alters prostanoid profile in human endothe-lial cells: role of protein kinase C and reactive oxygen species. Circulation, 2003, 107(7): 1017-1023.
  • 8Zochodne DW. Diabetic neuropathies: features and mechanisms. J Brain Pathol, 1999, 9(2): 369-391.
  • 9Weiswasser JM, Arora S, Shuman C, et al. Diabetic neuropathy. J Semin Vasc Surg, 2003, 16(1): 27-35.
  • 10Yagihashi S. Pathology of diabetic neuropathy; a review from the updated literature of the last 10 years. Nippon Rinsho, 2002, 60 ( Suppl 10): 204-208.

共引文献26

同被引文献27

引证文献5

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部